|
|
|
| Regulatory Effect of Comprehensive Treatment with Blue Light Irradiation on Serum Indexes of Neonatal Hemolysis with Hyperbilirubinemia |
| LI Kequan, et al |
| Jiaozhou Central Hospital of Qingdao, Shandong Qingdao 266300, China |
|
|
|
|
Abstract Objective: To study the regulatory effect of blue light irradiation combined with comprehensive treatment on serum indexes of hyperbilirubinemia caused by hemolytic disease of the newborn. Methods: 90 children with hyperbilirubinemia caused by hemolytic disease of the newborn were randomly divided into two groups: the intervention group was treated with blue light irradiation combined with comprehensive drug treatment; the control group was treated with comprehensive drug treatment. The levels of TBIL, MDA, neurofunctional molecules, liver and kidney functional molecules were detected before and after treatment. Results: With one case in the intervention group being ineffective, the total effective rate was 97.78% (44/45), significantly higher than that in the control group (χ2=10.88, P=0.001). There was no difference in serum TBIL content between the two groups before treatment; After treatment, the serum TBIL content of the intervention group was significantly lower than that of the contro group (P<0.05). Before the treatment, there was no significant difference in the content of α - glutathione-s transferase and serum glutamate dehydrogenase between the two groups; after the treatment, the content of serum glutamate dehydrogenase in the intervention group was lower than that in the control group (P<0.05). There was no difference in serum MDA between the two groups before treatment, while, After treatment, the serum MDA content of the combined group decreased significantly, which was lower than that of the drug group (P<0.05). There was no difference in serum NSE content between the two groups before treatment; after treatment, the serum NSE content of the intervention group was significantly lower than that of the control group (P<0.05). Conclusion: In the treatment of hyperbilirubinemia, the combination of blue light irradiation and comprehensive treatment has a good effect. It not only effectively reduces the bilirubin content, but also protects children's nerve function, which has an extremely important clinical application value.
|
|
|
|
|
|
[1] 姚超峰.脐带血血清总胆红素检测在新生儿ABO溶血病早期诊治中的临床价值[J].河北医学, 2018, 24(5):730~734.
[2] 胡小苹.经皮黄疸仪在黄疸新生儿中的应用效果[J].医疗装备, 2019, 32(20):50~51.
[3] 王玲.新生儿高胆红素血症应用蓝光治疗的皮肤护理重要性探讨[J].中国医药指南, 2019, 17(29):11~13.
[4] 魏春晖.强光疗治疗新生儿高胆红素血症的疗效观察[J].中国卫生标准管理, 2019, 10(19):48~49.
[5] 陈运彬, 黄为民, 黄磊, 等.新生儿黄疸规范化用药指导专家建议[J].中国医药导报, 2019, 16(27):105~110.
[6] 周贵平.新生儿高胆红素血症蓝光治疗80例护理体会[J].世界最新医学信息文摘, 2019, 19(75):264~265.
[7] 赵炜琨.白蛋白对新生儿高胆红素血症的治疗效果[J].深圳中西医结合杂志, 2019, 29(12):112~114.
[8] 唐萍, 王琦.新生儿高胆红素血症蓝光治疗应用抚触护理的体会[J].心血管外科杂志(电子版), 2018, 7(4):786~787.
[9] 葛敏, 唐军.新生儿重症高胆红素血症治疗进展[J].中华妇幼临床医学杂志(电子版), 2018, 14(3):360~367. |
|
|
|
2020, Vol. 26 
